-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Brokerages Set KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) PT at $23.80
Shares of KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) have been given a consensus recommendation of “Buy” by the seven ratings firms that are presently covering the stock, Marketbeat reports. Six research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […]
Shares of KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) have been given a consensus recommendation of “Buy” by the seven ratings firms that are presently covering the stock, Marketbeat reports. Six research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […]
